Initials:.. Number of patient in the registry:... Date of visit:.. Gender (genetic): female / male

Similar documents
Pituitary Adenomas: Evaluation and Management. Fawn M. Wolf, MD 10/27/17

Mechanism of hyperprolactinemia

PITUITARY: JUST THE BASICS PART 2 THE PATIENT

Pituitary for the General Practitioner. Marilyn Lee Consultant physician and endocrinologist

Functional Pituitary Adenomas. Fawn M. Wolf, MD 2/2/2018

Targeted Issues in Endocrinology Joshua S. Coren, DO, MBA, FACOFP

Treating a Growing Problem: A Closer Look at Acromegaly. Lisa Nachtigall, MD (Moderator) Nicholas Tritos, MD, DSc Brooke Swearingen, MD

UW MEDICINE PATIENT EDUCATION. Acromegaly Symptoms and treatments. What is acromegaly? DRAFT. What are the symptoms? How is it diagnosed?

Test Results SB Samples Arrived: 01/15/2014 Samples Collected: Saliva: 01/11/14 07:14 Date Closed: 01/18/2014

TEST REPORT # SB. Patient Name: Comprehensive Male Profile I Patient Phone Number: TEST NAME RESULTS 08/12/18 RANGE

Reproductive Health and Pituitary Disease

Somatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234)

Therapeutic Cohort Results

GLMS CME- Cell Group 5 10 April Greenlane Medical Specialists Pui-Ling Chan Endocrinologist

Pituitary Stalk Interruption Syndrome. Leena Shahla, MD, PGY5 Endocrinology, Diabetes and Metabolism Fellowship University of Massachusetts

Therapeutic Cohort Results

62-year-old woman with severe headache. Celeste Thomas November 1, 2012

JACK L. SNITZER, DO INTERNAL MEDICINE BOARD REVIEW COURSE 2018 PITUITARY

PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS:

One Day Hormone Check

in Primary Care (Part 2) Jonathan R. Anolik, MD, FACP, FACE Lewis Katz School of Medicine at Temple University

JOHN MICHAEL ROACH, MD

(3) Pituitary tumours

HYPOTHALAMO PITUITARY GONADAL AXIS

Pituitary Disorders Suranut Charoensri, MD

Professor Ian Holdaway. Endocrinologist Auckland District Health Board

Therapeutic Cohort Results

One Day Hormone Check

Introduction to Endocrinology. Hypothalamic and Pituitary diseases Prolactinoma + Acromegaly

Patient History Form

More than meets the eye

New Patient History Form

Female Patient Questionnaire & History

PERSONAL MEDICAL AND FAMILY HISTORY Please check applicable boxes.

MenoChat. City State Zip Code. Employer Job Title. Primary Care Provider Phone: History. Desired Outcome:

What we will cover. Evaluation of the Child with Suspected Pituitary Disease. ituitary

Testosterone Therapy in Men with Hypogonadism

Hormones by location

8605 SW Creekside Place Beaverton, OR Phone: Fax: Height 5 ft 8 in BMI Weight 154 lb

Overview of Reproductive Endocrinology

Personal Data. Present Symptoms

Pituitary Gland Disorders

Amarillo Surgical Group Doctor: Date:

Pure Health Natural Medicine

Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology

ENDOCRINE SYSTEM 29 MAY 2013

Imaging pituitary gland tumors

Accession #: Patient: Jane Doe Convert to pdf, Save or PRINT >> ADRENAL CHECK

CECILIA P MARGRET MD PhD MPH Child, Adolescent and Adult Psychiatry NE 24th ST Suite 104, Bellevue WA 98007, Phone / Fax: +1 (425)

Male Hypogonadism. Types and causes of hypogonadism. What is male hypogonadism? Symptoms. Testosterone production. Patient Information.

Endocrine part one. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy

Table of Contents. What Is Hypopituitarism? What Causes Hypopituitarism? What It Means to You... 4

PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)

Endocrinological Outcome Among Treated Craniopharyngioma Patients

Kimberley A. Schroeder, D.O. 115 Baker Drive Tomball, TX

10 Essential Blood Tests PART 2

BROADWAY SPORTS & INTERNAL MEDICINE, P.S TH AVE NE SUITE 202 BELLEVUE, WA P: F:

DOB: / / Please list the names and telephone numbers of the other physicians involved in your care: Name Specialty Phone Address Receive Report (Y/N)

The information you provide us will greatly help us provide the highest quality and most comprehensive care for you.

Some Issues in the Management of Hypothyroidism

Evaluation and Management of Pituitary Failure. Dr S. Ali Imran MBBS, FRCP (Edin), FRCPC Professor of Medicine Dalhousie University, Halifax, NS

THE OB/GYN CENTRE NEW PATIENT HISTORY

NANOS Patient Brochure

Sexual dysfunction of chronic kidney disease. Razieh salehian.md psychiatrist

Regula'ng Body Func'on

26 YEAR-OLD FEMALE WITH HEADACHES AND OLIGOMENORRHEA

CYSTIC PROLACTINOMA: A SURGICAL DISEASE?

THE THYROID. Your thyroid evaluation may include the following:

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

03-Dec-17. Thyroid Disorders GOITRE. Grossly enlarged thyroid - in hypothyroidism in hyperthyroidism - production of anatomical symptoms

Name: Date: Referring Provider: What is the nature of your current gynecologic or urologic medical problem (use the other side if necessary).

INFORMED CONSENT FOR FEMINIZING HORMONE THERAPY

GUIDELINES ON. Introduction. G.R. Dohle, S. Arver, C. Bettocchi, S. Kliesch, M. Punab, W. de Ronde

Mercy MS Center New Patient Information

NEW GYN PATIENT HISTORY FORM (OB PATIENTS, please DO NOT USE THIS FORM. Thanks.)

Ch 8: Endocrine Physiology

Test Results SB Samples Arrived: 04/06/2016 Samples Collected: Saliva: 04/04/16 06:45. Saliva: 04/04/16 11:30

Bodily Conditions Rooted in Hormone Imbalance

Robert Wadlow and his father

Review of Systems NAME: DATE OF BIRTH: DATE COMPLETED: Dear Patient,

Clinical evaluation of infertility

Case Report Rapid Pituitary Apoplexy Regression: What Is the Time Course of Clot Resolution?

Name: Date of Birth: Age: Address: City State Zip

Thyroid Disorders. January 2019

Pituitary adenomas and menopause

! 30 E Padonia Rd, #305, Timonium, MD Phone: (410) Fax: (443)

DIVISION OF CARDIOLOGY

High and Low GH: an update of diagnosis and management of GH disorders

Lab Guide Endocrine Section Lab Guide

Scrub In. TSH is secreted by the pituitary and acts on the: Parathormone tends to increase the concentration of:

Female New Patient Package

PATIENT INFORMATION HYPOPITUITARISM YOUR QUESTIONS ANSWERED

Female Patient Questionnaire & History

Patient Intake Form for Allegany Ear, Nose, & Throat

Who is filling out this intake form? Self Spouse Parent Guardian

Medical History Form

Barns Medical Practice Service Specification Outline: Hypothyroidism

HORMONE BALANCE QUESTIONNAIRE FOR WOMEN

Transcription:

1. Patient personal details Institute code: Physician code: Initials:.. Number of patient in the registry:... Date of visit:.. Gender (genetic): female / male 2. Changes in acromegaly-specific medical history Any significant changes or new significant symptoms of acromegaly: - If yes, please specify: - Swelling of extremities [ * ] [1] No significant changes / Symptom is over / Improvement / / No data Improvement / worsening degree: - mild / moderate / considerable [2] New significant symptom: mild / moderate / severe - Excessive sweating and body odor [ * ] [1] No significant changes / Symptom is over / Improvement / / No data Improvement / worsening degree: - mild / moderate / considerable [2] New significant symptom: mild / moderate / severe - Joint pain [ * ] [1] No significant changes / Symptom is over / Improvement / / No data Improvement / worsening degree: - mild / moderate / considerable [2] New significant symptom: mild / moderate / severe - Fatigue and muscle weakness [ * ] If yes, [[1] No significant changes / Symptom is over / Improvement / / No data

Improvement / worsening degree: - mild / moderate / considerable [2] New significant symptom: mild / moderate / severe - Headaches [ * ] [1] No significant changes / Symptom is over / Improvement / / No data Improvement / worsening degree: - mild / moderate / considerable [2] New significant symptom: mild / moderate / severe ( [ * ] mild: 1 point, moderate: 2 point, severe: 3 point) Acromegaly severity score (0-15 point):. - Enlarged hands [1] [2] / Increase of shoe size [1] [2] / Coarsened, enlarged facial features [1] [2] / Coarse, oily, thickened skin [1] [2] / Small outgrowths of skin tissue (skin tags) [1] [2] / A deepened, husky voice [1] [2] / Severe snoring [1] [2] / Impaired vision [1] [2] / Visual field defects [1] [2] / Enlarged tongue [1] [2] / limited joint mobility [1] [2] / Increased chest size (barrel chest) [1] [2] / Increased distance between teeth [1] [2] / Other [1] [2] :.. [1] No significant changes / Symptom is over / Improvement / / No data [2] New significant symptom Any significant changes in other symptoms or new significant symptoms: - If yes, please specify: Decreased body and facial hair [1] [2] / Thinning hair [1] [2] / Erectile dysfunction [1] [2] / Gynecomastia [1] [2] / Loss of interest in sexual activity [1] [2] / Infertility [1] [2] / Irregular menstrual periods (oligomenorrhea) or no menstrual periods (amenorrhea) [1] [2] / Galactorrhea [1] [2] / Painful intercourse [1] [2] / Acne [1] [2] / Hirsutism [1] [2] / Lightheadedness [1] [2] / Fatigue [1] [2] / Body aches [1] [2] / Low blood pressure [1] [2] / Unexplained weight loss [1] [2] / Weight gain [1] [2] / Increased sensitivity to cold [1] [2] / Constipation [1] [2] / Dry skin [1] [2] / Puffy face [1] [2] / Hoarseness [1] [2] / Muscle weakness [1] [2] / Decrease in muscle mass [1] [2] / Muscle aches, tenderness and stiffness [1] [2] / Depression [1] [2] / Impaired memory [1] [2] / Difficulty in focusing attention [1] [2] / Other [1] [2] :..

[1] No significant changes / Symptom is over / Improvement / / No data [2] New significant symptom Laboratory results Any significant change in the laboratory results If yes: Date of investigation:........ Hormones: yes / no - IGF-1: - unit:. ng/ml calculator. nmol/l - Upper limit of normal (ULN):. Upper limit of normal ratio (ULNR):. - GH (baseline, 0 min.): - unit:. ng/ml calculator mu/l - GH (lowest value during an OGTT): - unit:. ng/ml calculator. mu/l - Prolactin: - unit:. ng/ml calculator. mu/l - TSH: - unit:. mu/l - FT4: - unit:. pmol/l calculator. ng/dl - ACTH: - unit:. pmol/l calculator. pg/ml

- Cortisol: - unit:. nmol/l calculator. μg/dl - FSH: - LH: - unit:. U/L - unit:. U/L - Testosterone : - unit:. nmol/l calculator. ng/ml - Estradiol : - unit:. pmol/l calculator. pg/ml Biochemical control of acromegaly: - controlled / partially controlled / uncontrolled / no data Findings of pituitary insufficiency: Hypadrenia - No significant changes / Finding is over / Improvement / / No data or - New significant finding Hypothyroidism - No significant changes / Finding is over / Improvement / / No data or - New significant finding

Hypogonadism - No significant changes / Finding is over / Improvement / / No data or - New significant finding Diabetes insipidus - No significant changes / Finding is over / Improvement / / No data or - New significant finding - If new significant finding: Excretion of more than 4 liter urine: New radiological image: If yes: Date of imaging:....... Imaging modality: CT / MRI Maximal diameters of the tumor (3D if assessed):. [mm] Size category: micro /macro / giant / not visualized /empty sella / no data. Sinusoidal invasion: yes / no / not known / no data. Optic chiasm: no contact / contact / displaced / no data. Ectopic: yes / no / not known. Change from the previous investigation: no change / decreased / increased / no data. 3. Any significant changes in details from the medical history

Dysglycemia: - New significant dysglycemia - Since when: - Controlled by treatment: Lipid metabolism disorder: - New significant disorder of lipid metabolism: - Since when: - Controlled by treatment: Hypertension: - Newly discovered hypertension - Since when: - Controlled by treatment: Cardiomyopathy: - Any significant changes in the cardiomyopathy - Changes in the ECG: - If yes: Any significant changes in AV conduction abnormality Any significant changes in rhythm abnormality Any significant changes in left ventricular hypertrophy

Any significant changes in bundle branch block Any significant changes in ischemic lesion Any significant changes in QTc prolongation Any significant changes in other:. - Any significant changes in echocardiography: If yes: - date of examination:........ - EF [%]:. - Any significant changes in degree of left ventricular hypertrophy: - Heart failure: / No data. Highest NYHA grade (I-IV):. - New cardiomyopathy - Since when:.. - ECG abnormality: - If yes: AV conduction abnormality Rhythm abnormality Left ventricular hypertrophy Bundle branch block Ischemic lesion QTc prolongation Other:. - Echocardiography:

If yes: - date of examination:....... - EF [%]:. - Degree of left ventricular hypertrophy: no / mild /moderate /severe. - Heart failure: yes / no If yes: - Since when:.. - Required hospitalization: yes / no - Highest NYHA grade (I-IV): Sleep apnoe: - Any new sleep apnoe: - When was discovered:.. - Controlled by treatment: yes / no / not applicable / nincs adat Stroke: - Any new stroke: - When was discovered: Renal failure: - No significant changes / Finding is over / Improvement / - Lowest egfr [ml/min/1.73m 2 ]:. - Any new significant renal failure: - Since when:.. - Lowest egfr [ml/min/1.73m 2 ]:. - Controlled by treatment: yes / no / not applicable Malignant tumor - No significant changes / Disease is over / Improvement / / No data

- Any new malignant tumor: If yes, type: Brain tumor / Thyroid gland tumor / Gastrointestinal tumor / Hematological tumor / Tumor of the skin and-or soft tissue / Urological tumor / Gynecological tumor / Breast cancer / Other (please describe):.. When was discovered (year):.. Colonic polyp(s): - Any new colonic polyp(s): yes / no /not known / no data - When was discovered:.. Other, benign tumor: - Any new other, benign tumor: - When was discovered:.. Carpal tunnel syndrome: - Any new carpal tunnel syndrome: - Since when:.. Bone disorder: - No significant changes / Disorder is over / Improvement / / No data - New significant changes in bone disorder: - Since when:..

Fracture(s): - DEXA: yes /no / no data lumbal / femoral / other. - Other:. T-score:. Z-score:. - No significant changes / Disorder is over / Improvement / / No data - Any new fracture(s): - When happened:.. - Region: vertebral / hip / wrist / other. - Other:.. Neuro-psychiatric disorder(s): - No significant changes / Disorder is over / Improvement / / No data - Any new significant neuro-psychiatric disorder(s) - When was diagnosed: - Type: Depression / Anxiety disorder / Chronic pain syndrome / Cognitive problems / Other (please describe):. Other disorder(s): - No significant changes / Disorder is over / Improvement / / No data - Any new significant other disorder(s): - What disorder:.. - Since when:.. Non-pituitary surgery: Pregnancy: - Recent (non-pituitary) surgery: - What was: - When:..

- Any new pregnancy: - When:.. - Delivery: yes / no Alcohol consumption: - No significant changes / Stopped consuming alcohol / Improvement / / No data - Any significant new alcohol consumption: - Frequency: not available / occasionally / monthly / weekly / daily. - Amount (per occasion):. - For how many years?. Smoking habits: - No significant changes / stopped smoking / Improvement / / No data Drug abuse: Any significant new smoking habits: - Amount (cigarettes/day):. - Since when:. - No significant changes / stopped smoking / Improvement / / No data Any new significant drug abuse: - Type of drug:.. - Amount:.... - For how many years and/or month if available:. 4. Any significant changes in family history If yes: Tumorous disease in family history: - Pituitary tumor: yes / no yes / no / not available

daughter / son / other (please describe):.. - Brain tumor: yes / no - Thyroid gland tumor: yes / no - Gastrointestinal tumor: yes / no - Hematological tumor: yes / no - Skin/ soft tissue tumor: yes / no - Urological tumor: yes / no - Gynecological tumor: yes / no

- Breast cancer: yes / no - Other:.. - Relationship to patient*: New diseases: if yes: please list/describe them:.. 5. Any significant changes in treatment of acromegaly Any change in the therapy: Any new surgical therapy: yes / no FORM C - Surgical therapy Any significant changes in the medical therapy: yes / no FORM D - Medical therapy Any new radiotherapy: yes / no FORM E - Radiotherapy

6. Any significant changes in relevant, not acromegaly medications taken regularly: If yes: Medication: Active substance:... Dose:. g or. mg or. IU How many times per day (e.g. 3):. Method of administration: oral / nasal / transdermal / subcutaneous / intramuscular / intravenous/ other. - other:.. Other notes:... 7. Outcome Not available for endocrine care/ Regular follow-up / Death * / No data. * Date of death:........